Additionally, patients with pre-existing VEGFR-2-specific T cells showed a strong correlation with greater reductions in tumor perfusion, indicating that the reactivation of pre-existing memory T cells may, at least in part, contribute to vaccine efficacy [41]. This evidence concerns the gene KDR and neoplasm.